Obesity is a treatable challenge

Your efforts have a new ally.

Obesity is much more than an aesthetic issue, it is a chronic disease.

It affects multiple body systems and can have serious consequences if not treated in time.

Obesity is recognized as one of the leading preventable causes of death in the world. It is estimated that obesity causes 2.8 million deaths each year.

The link to type 2 diabetes

Obesity is a chronic disease that already affects more than 1 billion people worldwide, and is behind the 44% of cases of type 2 diabetes

Type 2 diabetes accounts for between 85 % and the 90 % of total diabetes cases globally

The situation in Paraguay

In Paraguay, the challenge is at home: a 32 % of the adult population lives with obesity, and if we add overweight, that figure reaches 69 %. At the same time, close to 9 to 10 % of adults are already living with type 2 diabetes

related diseases

Type 2 diabetes

More than 80% of type 2 diabetes cases are linked to excess weight.

Hypertension

Even a small weight reduction can significantly improve blood pressure People with obesity have up to twice the risk of coronary heart disease.

Cardiovascular diseases:

People with obesity have up to twice the risk of coronary heart disease.

Fatty liver:

Fat accumulation in the liver, even without alcohol consumption, can be silent for years. This can lead to liver inflammation, cirrhosis, liver failure, and liver failure.

Sleep apnea:

Many people with obesity snore without knowing they have apnea. Fat around the neck and throat obstructs the airway during sleep.

Joint problems:

Joints, especially knees and hips, bear more weight than they can tolerate. For every extra kilogram, your knees receive 4 kg more pressure when you walk.

Related cancers:

Chronic inflammation and hormonal imbalances increase the risk of some types of cancer. Obesity is the second leading preventable cause of cancer after smoking.

Mental health:

Stigma, frustration and hormonal changes affect emotional well-being; this increases the risk of anxiety, depression, social isolation and low self-esteem. 

What is LIPOLESS (tirzepatide) and what is its indication?

LIPOLESS is the trade name of an innovative drug whose active ingredient is tirzepatide. It is an injectable treatment that acts in a very specific way on the metabolism, and is mainly indicated for the treatment of people with obesity or overweight and type II diabetes.

Tirzepatide is what in medicine is called a dual GLP-1 and GIP receptor agonist, that is, it mimics two natural hormones that regulate appetite and blood sugar; helping to control hunger, improve insulin sensitivity and promote sustained and clinically significant weight loss.

How does it work? 

Lipoless mimics two natural hormones that are activated by eating: GLP and GIP.

LPG

  • Releases insulin
  • Low blood sugar
  • Prolongs satiety

GIP

  • Reinforces GLP-1 action
  • Better appetite control
  • Improved glucose control

Combined action

Reduced appetite + Improved metabolism 

It is crucial to remember that the decision to initiate treatment with tirzepatide should be made in conjunction with a physician. A healthcare professional is the only one who can evaluate your medical history, your specific needs and determine if this medication is the safe and appropriate choice for you.

FIND OUT IF LIPOLESS IS FOR YOU

If you have type 2 diabetes and want to improve your control.

If you are obese (BMI ≥ 30) or overweight (BMI ≥ 27) with associated conditions.

If you are committed to a healthier lifestyle.

If you are looking for a medical solution backed by science.

You are committed to making lifestyle changes.

You have no inconvenience with self-administration of subcutaneous injections.

Upcoming launch

VIAL PRESENTATIONS

PREFILLED SYRINGES

mode of use

Where to buy Lipoless?

*The purchase of this medicine is subject to the presentation of a prescription issued by a licensed professional.

Did you know that we have a patient patient support program?

Do you have any doubts?

Leave us your inquiry

a

a

a

In case of suspicion of the appearance of Adverse Reactions after the administration of the drug, it is mandatory to notify through the channels enabled by Laboratorio de Productos Eticos C.E.I.S.A: Telephone (07:15 to 17:15 hs): +595 21 521 390 - Int. 463 Telephone (24 hours available): +595 991 204 971 E-mail: farmacovigilancia@eticos.com.py
By accessing the following QR - Pharmacovigilance option:

This site is for informational purposes only. Information on Lipoless® is not a substitute for medical advice. Always consult a healthcare professional.

About Eticos

We are an international pharmaceutical group, committed to the discovery, development and sale of innovative products with high added value, which contribute to the improvement and care of people's health.

Type 2 diabetes

You have type 2 diabetes and are looking for advanced blood sugar (HbA1c) control, especially if other treatments have not been sufficient to reach your goals.

OBESITY

You struggle with obesity or being overweight and also have at least one weight-related medical condition such as high blood pressure, high cholesterol or sleep apnea.

Healthy living

You are looking for significant and sustained weight loss, as this drug has shown comparable results to bariatric surgery in some studies.

Medical solution

You want a single treatment that powerfully addresses both type 2 diabetes and excess weight, simplifying your medical regimen.

Lifestyle changes

Medication is a very effective tool, but it works best in combination with a healthy diet and regular physical activity.

Administration

Self-administration of a weekly subcutaneous injection is a practical treatment method that gives you more control over your health.

With simple training from a professional, you will learn how to apply the medication quickly and safely to areas such as the abdomen or thighs.

Our program

We provide support and guidance on how to use the product correctly.

This service does not replace a medical consultation.

Important information

In case of suspicion of the appearance of Adverse Reactions after the administration of the medicine, the notification through the channels enabled by Laboratorio de Productos Eticos C.E.I.S.A. is mandatory:

Phone (07:15 a.m. to 5:15 p.m.): +595 21 521 390 - Int. 463Telephone (24 hours available): +595 991 204 971
E-mail: farmacovigilancia@eticos.com.py